Canada markets closed

Insmed Incorporated (INSM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
56.98+3.43 (+6.41%)
At close: 04:00PM EDT
56.91 -0.07 (-0.12%)
After hours: 07:55PM EDT
Full screen
Loading interactive chart...
  • PR Newswire

    Insmed to Host Commercial Webinar on June 4, 2024

    Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, will host a commercial webinar on Tuesday, June 4, 2024, at 8:00 a.m. ET to discuss the market outlook for the Company's three most advanced programs, ARIKAYCE® (amikacin liposome inhalation suspension), brensocatib, and treprostinil palmitil inhalation powder (TPIP).

  • PR Newswire

    Insmed Announces Pricing of $650 Million Public Offering of Common Stock

    Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it priced an underwritten public offering of 12,621,359 shares of its common stock at a price to the public of $51.50 per share. The gross proceeds to Insmed from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Insmed, are expected to be approximately $650 million. I

  • Zacks

    Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data

    Data from a late-stage study shows that treatment with Insmed's (INSM) brensocatib reduced episodes of worsening disease symptoms in patients with bronchiectasis, a chronic lung condition.